Dr Caroline Austin
Dr Caroline Austin is Vice President, Head of Transactions, Business Development at AstraZeneca, Cambridge.
She has led partnering activities with multiple diagnostic partners across molecular diagnostics, tissue diagnostics and next generation sequencing. She also represented AstraZeneca in negotiating the consortium for the whole genome sequencing of the UK Biobank participants.
Caroline originally joined Astra as a bioscientist twenty four years ago, holding positions in the respiratory & inflammation area. She received herBSc and MSc from King’s College London, a PhD in Pharmacology at University College London, and a Post-Doctoral Fellowship in Clinical Immunology from the Johns Hopkins University School of Medicine, Baltimore USA. She is an Associate at the Cambridge Judge Business School.